During the past decade, Phoebe Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoebe Cancer Center" #1 sponsor was "Celgene" with 2 trials, followed by "Puma Biotechnology, Inc." with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Novacea" with 1 trials sponsored and "SCRI Development Innovations, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoebe Cancer Center" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Pharmacia and Upjohn" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Phoebe Cancer Center" are "Breast Cancer" (2 trials), "Metastatic Pancreatic Cancer" (1 trials), "Neoplasms, Unknown Primary" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Phoebe Cancer Center" in a lesser frequency.

Most popular intervention types in "Phoebe Cancer Center" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "placebo" (2 trials) and "Albumin-bound paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phoebe Cancer Center" are 4 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Phoebe Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Phoebe Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Phoebe Cancer Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".